Tissue Expression, Serum and Salivary Levels of IL-10 in Patients with Head and Neck Squamous Cell Carcinoma |
Hamzavi, Marzieh
(Department of Oral and Maxillofacial Pathology, Shiraz University of Medical Sciences)
Tadbir, Azadeh Andisheh (Department of Oral and Maxillofacial Pathology, Shiraz University of Medical Sciences) Rezvani, Gita (Department of Oral and Maxillofacial Pathology, Shiraz University of Medical Sciences) Ashraf, Mohammad Javad (Department of Pathology, School of Medicine, Shiraz University of Medical Sciences) Fattahi, Mohammad Javad (Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences) Khademi, Bijan (Department of Otolaryngology, Khalili Hospital, Shiraz University of Medical Sciences) Sardari, Yasaman (Department of Oral and Maxillofacial Pathology, Shiraz University of Medical Sciences) Jeirudi, Naghmeh (School of Dentistry, Shiraz University of Medical Sciences) |
1 | Alhamarneh O, Agada F, Madden L, et al (2010). Serum IL-10 and Circulating CD4+CD25inch regulatory T cell numvers aspredictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma. Head Neck, 10, 415-23. |
2 | Asadullah S, Sterry W, Volk HD (2003). Interleukin-10 Therapy-Review of a new Approch. Pharmacol Rev, 55, 241-69. DOI ScienceOn |
3 | Berman RM, Suzuki T, Tahara H, et al (1996). Systemic administration of cellular IL-10 induces an effective, specific c, and long-lived immune response against established tymors in mice. J Immunol, 157, 231-8. |
4 | Berzofsky JA, Terabe M (2009). The contrasing roles of NKT cells in tumor immunity. Curr Mol Med, 9, 667-72. DOI |
5 | Brooks M, Wang J, Li Y, et al (2008). Salivary protein factors are elevated in breast cancer patients. Nip Publish Access Author Manuscript, 1, 75-378. |
6 | Cervenak L, Morbidelli L, Donati D, et al (2000). Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by Interleukin-10. Blood, 96, 2568-73. |
7 | Chandler S, Rassekh C, Roadman S, et al (2002). Immunohistochemical localization of Interleukin-10 in human oral and pharyngeal carcinoma. Laryngoscope, 112, 808-15 DOI ScienceOn |
8 | DiLillo DJ, Matsushita T, Tedder TF (2010). B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann NY Acad Sci, 1183, 38-57. DOI ScienceOn |
9 | Fujieda SH, Sunaga H, Tsuzuki H, et al (1999). IL-10 expression is associated with the expression of platelet-derived endothelial cell growth factor and prognosis in oral and oropharyngeal carcinoma. Cancer Letter, 136, 1-9. DOI ScienceOn |
10 | Hoffmann TK, Sonkoly E, Homey B (2007). Aberrant cytokine expression in serum of patients with adenoid cystic carcinoma and squamous cell carcinoma of the head and neck. Head Neck, 29, 472-8. DOI ScienceOn |
11 | Lathers DM, Young MR (2004). Increased aberrance of cytokine expression in plasma of patient with more advanced squamous cell carcinoma of the head and neck. Cytokine, 25, 220-8. DOI ScienceOn |
12 | Linkov F, Lisovich A, Yurkovetsky Z (2007). Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling. Cancer Epidemiol Biomarkers Prev, 16, 102-7. DOI ScienceOn |
13 | Liu J, Song B, Wang JL, et al (2011). Polymorphisms of Interleukin-10 promoter are not associated with prognosis of advanced gastric cancer. World J Gastroenterol, 17, 1362-7 DOI ScienceOn |
14 | Nelson EL, Wenzel LB, Osann K, et al (2008). Stress, immunity and cervical cancer: biobehavioral outcomes of a randomized clinical trial. Clin Cancer Res, 14, 2111-8. DOI ScienceOn |
15 | Sabat R, Grutz G, Warszawska K, et al (2010). Biology of interleukin-10. Cytokine Growth factor REV, 21, 331-44. DOI ScienceOn |
16 | Shang ZJ, Li JR, Li ZB (2007). Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma. J Oral Maxillofact Surg, 65, 17-21. DOI ScienceOn |
17 | Sparano A, Lathers DM, Achille N, et al (2004). Modulation of TH1 and TH2 cytokine profiles and their association with advanced head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg, 131, 573-6. DOI ScienceOn |
18 | Toiyama Y, Miki C, Inoue Y, et al (2010). Loss of tissue expression of IL-10 promotes the disease progression of colorectal carcinoma. Surg Today, 46, 46-53. |
19 | Stearns ME, Rhim J, Wang M (1999). Interleukin-10(IL-10) inhibition of primary human prostate cellinduced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion. Clin Cancer Res, 5, 189-96. |
20 | Teles RP, Likhari V, Socransky SS, et al (2009). Salivary cytokine levels in chronic periodontitis and periodomtally healthy subjects. A cross-sectional study. J Periodontal Res, 44, 411-7. DOI ScienceOn |
21 | Wozniak KL, Arribas A, Leigh JE, et al (2002). Inhibitory effects of whole and parotid saliva on immunomodulators. Oral Microbiol Immunol, 17, 100-7. DOI |
22 | Zheng LM, Ojcius DM, Garaud F, et al (1996). Interleukin-10 inhibits tumor metastasis through an NK cell dependent mechanism. J Exp Med, 184, 579-84. DOI |